Flora Growth Corp. Files 8-K

TL;DR

Flora Growth filed an 8-K on 9/29/25, check it for updates.

AI Summary

Flora Growth Corp. filed an 8-K on September 29, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about the nature of these events or financial statements within the provided text.

Why It Matters

This filing indicates Flora Growth Corp. has submitted a current report to the SEC, which may contain material updates for investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report without immediate indication of significant negative events.

Key Numbers

• 001-40397 — SEC File Number (Identifies the company's filing with the SEC.)
• 20250929 — Filing Date (Date the 8-K report was filed.)

Key Players & Entities

• Flora Growth Corp. (company) — Registrant
• September 29, 2025 (date) — Date of earliest event reported
• 3230 W. Commercial Boulevard, Suite 180 (address) — Principal executive offices
• Fort Lauderdale, Florida (location) — Principal executive offices location
• 001-40397 (identifier) — SEC File Number

FAQ

Key Financial Figures

• $3,450,000 — time to time, sell up to an additional $3,450,000 of common shares under its "at the mark
• $129,482 — ommon shares with an aggregate value of $129,482 under the Previous Prospectus Supplemen

Filing Documents

• form8k.htm (8-K) — 17KB
• exhibit5-1.htm (EX-5.1) — 14KB
• exhibit8-1.htm (EX-8.1) — 7KB
• exhibit5-1x001.jpg (GRAPHIC) — 3KB
• exhibit5-1xu003.jpg (GRAPHIC) — 6KB
• exhibit5-1xu004.jpg (GRAPHIC) — 8KB
• exhibit8-1x001.jpg (GRAPHIC) — 5KB
• 0001062993-25-015845.txt ( ) — 283KB
• flgc-20250929.xsd (EX-101.SCH) — 5KB
• flgc-20250929_cal.xml (EX-101.CAL) — 1KB
• flgc-20250929_def.xml (EX-101.DEF) — 22KB
• flgc-20250929_lab.xml (EX-101.LAB) — 46KB
• flgc-20250929_pre.xml (EX-101.PRE) — 25KB
• form8k_htm.xml (XML) — 3KB

01 Other Information

Item 8.01 Other Information. Flora Growth Corp. (the "Company") has filed a prospectus supplement (the "ATM Prospectus Supplement") to its effective U.S. registration statement on Form S-3 (File No. 333-274204) in connection with its "at the market" Sales Agreement with Revere Securities LLC, dated September 23, 2025. Pursuant to the ATM Prospectus Supplement, the Company may, at its discretion from time to time, sell up to an additional $3,450,000 of common shares under its "at the market" program. By filing the ATM Prospectus Supplement, the offering of common shares under the prospectus supplement dated September 23, 2025 (the "Previous Prospectus Supplement") is hereby terminated. The Company sold common shares with an aggregate value of $129,482 under the Previous Prospectus Supplement.

01. Exhibits

Item 9.01. Exhibits. Exhibit Description 5.1 Opinion of Fogler, Rubinoff LLP 8.1 Opinion of Dorsey & Whitney LLP 23.1 Consent of Fogler, Rubinoff LLP (included in Exhibit 5.1) 23.2 Consent of Dorsey & Whitney LLP (included in Exhibit 8.1) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. FLORA GROWTH CORP. (Registrant) Dated: September 29, 2025 By: /s/ Dany Vaiman Dany Vaiman Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR